StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Dr. Reddy's Laboratories Limited
NSE:DRREDDY.NS
Sector
Location
Market Cap
USD 12.69 B
Share Price
USD 14.60
Avg Daily Volume
1,908,493
Change (1 day)
-0.83%
Change (1 year)
-7.47%
Change (YTD)
-9.98%
Dr. Reddy's Laboratories Limited Operating Cash Flow for the year ending March 31, 2025: USD 543.30 M
Dr. Reddy's Laboratories Limited Operating Cash Flow is USD 543.30 M for the year ending March 31, 2025, a -0.26% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Dr. Reddy's Laboratories Limited Operating Cash Flow for the year ending March 31, 2024 was USD 544.70 M, a -23.96% change year over year.
-
Dr. Reddy's Laboratories Limited Operating Cash Flow for the year ending March 31, 2023 was USD 716.31 M, a 93.50% change year over year.
-
Dr. Reddy's Laboratories Limited Operating Cash Flow for the year ending March 31, 2022 was USD 370.18 M, a -24.08% change year over year.
-
Dr. Reddy's Laboratories Limited Operating Cash Flow for the year ending March 31, 2021 was USD 487.60 M, a 23.13% change year over year.
Competitors
Eli Lilly and Company
USD 793.01
LLY
+2.36
0.30%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
Regeneron Pharmaceuticals, Inc.
USD 567.74
REGN
+7.98
1.43%
Cencora, Inc.
USD 295.21
COR
-2.11
-0.71%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.93
600276.SS
-0.09
-1.14%
Takeda Pharmaceutical Company Limited
USD 29.69
4502.T
+0.05
0.17%
Haleon plc
USD 4.95
HLN.L
-0.10
-1.95%
Daiichi Sankyo Company, Limited
USD 22.09
4568.T
+0.15
0.69%
Ucb S.A.
USD 199.81
UCB.BR
-2.13
-1.05%
BeOne Medicines Ltd.
USD 250.30
ONC
-3.09
-1.22%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Eli Lilly and Company
USD 793.01
LLY
+2.36
0.30%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
Regeneron Pharmaceuticals, Inc.
USD 567.74
REGN
+7.98
1.43%
Cencora, Inc.
USD 295.21
COR
-2.11
-0.71%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.93
600276.SS
-0.09
-1.14%
Takeda Pharmaceutical Company Limited
USD 29.69
4502.T
+0.05
0.17%
Haleon plc
USD 4.95
HLN.L
-0.10
-1.95%
Daiichi Sankyo Company, Limited
USD 22.09
4568.T
+0.15
0.69%
Ucb S.A.
USD 199.81
UCB.BR
-2.13
-1.05%
BeOne Medicines Ltd.
USD 250.30
ONC
-3.09
-1.22%